Table 1.
The new or ongoing clinical trials to investigate the value of isoflavone in cancer clinic*.
| NCT ID | Title |
|---|---|
| NCT00617617 | The specific role of isoflavones in reducing prostate cancer risk |
| NCT00204490 | Soy isoflavones and breast cancer risk reduction |
| NCT00243048 | Isoflavones and radiation therapy in treating patients with localized prostate cancer |
| NCT00078923 | Soy isoflavones in treating patients who are undergoing radical prostatectomy for stage I or stage II PCa |
| NCT00200824 | Effects of soy compounds on breast cancer, prostate cancer, and bone health |
| NCT00003100 | Dietary soy isoflavones for the prevention of cancer |
| NCT00354432 | Soy protein/isoflavones and venlafaxine in treating hot flashes in patients receiving hormone therapy for prostate cancer |
| NCT00255125 | Role of soy supplementation in prostate cancer development |
| NCT00513916 | Effect of dietary soy on estrogens in breast fluid, blood, and urine samples from healthy women |
| NCT00499408 | Vitamin d and soy supplements in treating patients with recurrent prostate cancer |
| NCT00555386 | Soy, selenium and breast cancer risk |
| NCT00118040 | Genistein in patients who are undergoing surgery for bladder cancer |
| NCT00345813 | Soy supplements in treating patients undergoing surgery for localized prostate cancer |
| NCT00765479 | Soy protein in preventing recurrent cancer in patients who have undergone surgery for stage II prostate cancer |
| NCT00290758 | Genistein in preventing breast cancer in women at high risk for breast cancer |
| NCT00701584 | The role of diet and lifestyle in breast cancer survival |
| NCT00244933 | Gemcitabine hydrochloride and genistein in treating women with stage iv breast cancer |
| NCT00005827 | Genistein in treating patients with stage ii, stage iii, or stage iv prostate cancer |
| NCT00118040 | Genistein in patients who are undergoing surgery for bladder cancer |
| NCT00276835 | Genistein and interleukin-2 in treating patients with metastatic melanoma or kidney cancer |
| NCT00546039 | Synthetic genistein (bonistein™) in patients who are undergoing surgery for prostate cancer |
| NCT00290758 | Genistein in preventing breast cancer in women at high risk for breast cancer |
| NCT00376948 | Genistein, gemcitabine, and erlotinib in treating patients with locally advanced or metastatic pancreatic cancer |
| NCT00499408 | Vitamin D and soy supplements in treating patients with recurrent |
*
Information collected from ClinicalTrials.gov